Impact of tumor size on the difficulty of laparoscopic left lateral sectionectomies.


Journal

Journal of hepato-biliary-pancreatic sciences
ISSN: 1868-6982
Titre abrégé: J Hepatobiliary Pancreat Sci
Pays: Japan
ID NLM: 101528587

Informations de publication

Date de publication:
May 2023
Historique:
revised: 04 10 2022
received: 06 08 2022
accepted: 13 10 2022
pmc-release: 01 05 2024
medline: 26 5 2023
pubmed: 20 11 2022
entrez: 19 11 2022
Statut: ppublish

Résumé

Tumor size (TS) represents a critical parameter in the risk assessment of laparoscopic liver resections (LLR). Moreover, TS has been rarely related to the extent of liver resection. The aim of this study was to study the relationship between tumor size and difficulty of laparoscopic left lateral sectionectomy (L-LLS). The impact of TS cutoffs was investigated by stratifying tumor size at each 10 mm-interval. The optimal cutoffs were chosen taking into consideration the number of endpoints which show a statistically significant split around the cut-points of interest and the magnitude of relative risk after correction for multiple risk factors. A total of 1910 L-LLS were included. Overall, open conversion and intraoperative blood transfusion were 3.1 and 3.3%, respectively. The major morbidity rate was 2.7% and 90-days mortality 0.6%. Three optimal TS cutoffs were identified: 40-, 70-, and 100-mm. All the selected cutoffs showed a significant discriminative power for the prediction of open conversion, operative time, blood transfusion and need of Pringle maneuver. Moreover, 70- and 100-mm cutoffs were both discriminative for estimated blood loss and major complications. A stepwise increase in rates of open conversion rate (Z = 3.90, P < .001), operative time (Z = 3.84, P < .001), blood loss (Z = 6.50, P < .001), intraoperative blood transfusion rate (Z = 5.15, P < .001), Pringle maneuver use (Z = 6.48, P < .001), major morbidity(Z = 2.17, P = .030) and 30-days readmission (Z = 1.99, P = .047) was registered as the size increased. L-LLS for tumors of increasing size was associated with poorer intraoperative and early postoperative outcomes suggesting increasing difficulty of the procedure. We determined three optimal TS cutoffs (40-, 70- and 100-mm) to accurately stratify surgical difficulty after L-LLS.

Sections du résumé

BACKGROUND BACKGROUND
Tumor size (TS) represents a critical parameter in the risk assessment of laparoscopic liver resections (LLR). Moreover, TS has been rarely related to the extent of liver resection. The aim of this study was to study the relationship between tumor size and difficulty of laparoscopic left lateral sectionectomy (L-LLS).
METHODS METHODS
The impact of TS cutoffs was investigated by stratifying tumor size at each 10 mm-interval. The optimal cutoffs were chosen taking into consideration the number of endpoints which show a statistically significant split around the cut-points of interest and the magnitude of relative risk after correction for multiple risk factors.
RESULTS RESULTS
A total of 1910 L-LLS were included. Overall, open conversion and intraoperative blood transfusion were 3.1 and 3.3%, respectively. The major morbidity rate was 2.7% and 90-days mortality 0.6%. Three optimal TS cutoffs were identified: 40-, 70-, and 100-mm. All the selected cutoffs showed a significant discriminative power for the prediction of open conversion, operative time, blood transfusion and need of Pringle maneuver. Moreover, 70- and 100-mm cutoffs were both discriminative for estimated blood loss and major complications. A stepwise increase in rates of open conversion rate (Z = 3.90, P < .001), operative time (Z = 3.84, P < .001), blood loss (Z = 6.50, P < .001), intraoperative blood transfusion rate (Z = 5.15, P < .001), Pringle maneuver use (Z = 6.48, P < .001), major morbidity(Z = 2.17, P = .030) and 30-days readmission (Z = 1.99, P = .047) was registered as the size increased.
CONCLUSION CONCLUSIONS
L-LLS for tumors of increasing size was associated with poorer intraoperative and early postoperative outcomes suggesting increasing difficulty of the procedure. We determined three optimal TS cutoffs (40-, 70- and 100-mm) to accurately stratify surgical difficulty after L-LLS.

Identifiants

pubmed: 36401813
doi: 10.1002/jhbp.1279
pmc: PMC10195918
mid: NIHMS1851951
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

558-569

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : US National Cancer Institute MSKCC Core Grant
ID : P30 CA008747

Investigateurs

Chung-Yip Chan (CY)
Mikel Prieto (M)
Juul Meurs (J)
Celine De Meyere (C)
Felix Krenzien (F)
Moritz Schmelzle (M)
Kit-Fai Lee (KF)
Kelvin K Ng (KK)
Diana Salimgereeva (D)
Ruslan Alikhanov (R)
Lip-Seng Lee (LS)
Jae Young Jang (JY)
Kevin P Labadie (KP)
Yutaro Kato (Y)
Masayuki Kojima (M)
Asmund Avdem Fretland (AA)
Jacob Ghotbi (J)
Fabricio Ferreira Coelho (FF)
Jaime Arthur Pirola Kruger (JAP)
Victor Lopez-Lopez (V)
Paolo Magistri (P)
Margarida Casellas I Robert (MCI)
Kohei Mishima (K)
Roberto Montalti (R)
Mariano Giglio (M)
Alessandro Mazzotta (A)
Boram Lee (B)
Mizelle D'Silva (M)
Hao-Ping Wang (HP)
Mansour Saleh (M)
Franco Pascual (F)
Amal Suhool (A)
Phan Phuoc Nghia (PP)
Chetana Lim (C)
Qiu Liu (Q)
Prashant Kadam (P)
Bernardo Dalla Valle (B)
Eric C Lai (EC)
Maria Conticchio (M)
Ugo Giustizieri (U)
Davide Citterio (D)
Zewei Chen (Z)
Shian Yu (S)
Francesco Ardito (F)
Simone Vani (S)
Epameinondas Dogeas (E)
Tiing Foon Siow (TF)
Federico Mocchegianni (F)
Giuseppe Maria Ettorre (GM)
Marco Colasanti (M)
Yoelimar Guzmán (Y)

Informations de copyright

© 2022 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Références

Wakabayashi G, Cherqui D, Geller DA, Buell JF, Kaneko H, Han HS, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg. 2015;261(4):619-29.
Wakabayashi G. What has changed after the Morioka consensus conference 2014 on laparoscopic liver resection? Hepatobiliary Surg Nutr. 2016;5(4):281-9.
Halls MC, Berardi G, Cipriani F, Barkhatov L, Lainas P, Harris S, et al. Development and validation of a difficulty score to pre-dict intraoperative complications during laparoscopic liver resection. Br J Surg. 2018;105(9):1182-91.
Kabir T, Syn N, Koh YX, Teo JY, Chung AY, Chan CY, et al. Impact of tumor size on the difficulty of minimally invasive liver resection. Eur J Surg Oncol. 2022;48(1):169-76.
Russolillo N, Casella M, Langella S, Lo Tesoriere R, Ossola P, Ferrero A. Correlation between anthropometric data and preparatory maneuvers difficulties during laparoscopic right liver resec-tions: a single center prospective study. Surg Endosc. 2022;36:7343-51.
Goh BK, Prieto M, Syn N, Koh YX, Teo JY, Lee SY, et al. Validation and comparison of the Iwate, IMM, Southampton and Hasegawa difficulty scoring systems for primary laparoscopic hepatectomies. HPB. 2021;23:770-6.
Cheung TT, Wang X, Efanov M, Liu R, Fuks D, Choi GH, et al. Minimally invasive liver resection for huge (≥10 cm) tumors: an interna-tional multicenter matched cohort study with regression discontinuity analyses. Hepatobiliary Surg Nutr. 2021;10(5):587-97.
Goh BK, Kabir T, Syn N. RE: new simple three-level liver resection classification without compromising the performance to predict surgical and postoperative outcomes. Eur J Surg Oncol. 2022;46:303-4.
Hasegawa Y, Nitta H, Sasaki A, Takahara T, Ito N, Fujita T, et al. Laparoscopic left lateral sectionectomy as a training procedure for surgeons learning lap-aroscopic hepatectomy. J Hepatobiliary Pancreat Sci. 2013;20(5):525-30.
Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12(5):351-5.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-13.
Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, et al. World consensus conference on laparoscopic surgery. The international position on laparoscopic liver surgery: the Louisville statement, 2008. Ann Surg. 2009;250(5):825-30.
Abu Hilal M, Aldrighetti L, Dagher I, Edwin B, Troisi RI, Alikhanov R, et al. The Southampton consensus guidelines for laparoscopic liver surgery: from indication to implementation. Ann Surg. 2018;268(1):11-8.
Kabir T, Syn NL, Guo Y, Lim KI, Goh BKP. Laparoscopic liver resection for huge (≥10 cm) hepatocellular carcinoma: a coarsened exact-matched single-surgeon study. Surg Oncol. 2021;37:101569.
Goh BKP, Lee SY, Koh YX, Kam JH, Chan CY. Minimally invasive major hepatectomies: a southeast Asian single institution contemporary experience with its first 120 consecutive cases. ANZ J Surg. 2020;90(4):553-7.
Goh BKP, Lee SY, Teo JY, Kam JH, Jeyaraj PR, Cheow PC, et al. Changing trends and outcomes associated with the adoption of minimally invasive hepatectomy: a contemporary single-institution experience with 400 consecutive resections. Surg Endosc. 2018;32(11):4658-65.
Kawaguchi Y, Hasegawa K, Wakabayashi G, Cherqui D, Geller DA, Buell JF, et al. Survey results on daily practice in open and laparoscopic liver resections from 27 centers participating in the second international consensus con-ference. J Hepatobiliary Pancreat Sci. 2016;23(5):283-8.
Wang HP, Yong CC, Wu AG, Cherqui D, Troisi RI, Cipriani F, et al. Factors associated with an impact of open conversion on the outcomes of minimally-invasive left lateral sectionectomies: an international multicenter study. Surgery. 2022;172:617-24.
Ivanecz A, Plahuta I, Magdalenic T, Ilijevec B, Mencinger M, Peruš I, et al. Evaluation of the Iwate model for predicting the difficulty of laparoscopic liver resection: does tumor size matter? J Gastrointest Surg. 2021;25:1451-60.
Yang TH, Chen JL, Lin YJ, Chao YJ, Shan YS, Hsu HP, et al. Laparoscopic surgery for large left lateral liver tumors: safety and oncologic outcomes. Surg Endosc. 2018;32(10):4314-20. https://doi.org/10.1007/s00464-018-6287-9

Auteurs

Giada Aizza (G)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Nadia Russolillo (N)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Alessandro Ferrero (A)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Nicholas L Syn (NL)

Ministry of Health Holdings Singapore and Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Federica Cipriani (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Davit Aghayan (D)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Marco V Marino (MV)

General Surgery Department, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
Oncologic Surgery Department, P. Giaccone University Hospital, Palermo, Italy.

Riccardo Memeo (R)

Unit of Hepato-Pancreatc-Biliary Surgery, "F. Miulli" General Regional Hospital, Acquaviva delle Fonti, Bari, Italy.

Vincenzo Mazzaferro (V)

HPB Surgery, Hepatology and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Adrian K H Chiow (AKH)

Hepatopancreatobiliary Unit, Department of Surgery, Changi General Hospital, Singpore City, Singapore.

Iswanto Sucandy (I)

AdventHealth Tampa, Digestive Health Institute, Florida, Tampa, USA.

Arpad Ivanecz (A)

Department of Abdominal and General Surgery, University Medical Center Maribor, Maribor, Slovenia.

Marco Vivarelli (M)

HPB Surgery and Transplantation Unit, United Hospital of Ancona, Department of Sperimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy.

Fabrizio Di Benedetto (F)

Hepatopancreatobiliary Surgery and Liver Transplant Unit, University of Modena and Reggio Emilia, Modena, Italy.

Sung-Hoon Choi (SH)

Department of General Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea.

Jae Hoon Lee (JH)

Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

James O Park (JO)

Department of Surgery, University of Washington Medical Center, Washington, Seattle, USA.

Mikel Gastaca (M)

Hepatobiliary Surgery and Liver Transplantation Unit, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Bilbao, Spain.

Constantino Fondevila (C)

General and Digestive Surgery, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.

Mikhail Efanov (M)

Department of Hepato-Pancreato-Biliary Surgery, Moscow Clinical Scientific Center, Moscow, Russia.

Fernando Rotellar (F)

HPB and Liver Transplant Unit, Department of General Surgery, Clinica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain.
Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.

Gi-Hong Choi (GH)

Division of Hepatopancreatobiliary Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.

Ricardo Robles-Campos (R)

Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de la Arrixaca, IMIB-ARRIXACA, Murcia, Spain.

Xiaoying Wang (X)

Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

Robert P Sutcliffe (RP)

Department of Hepatopancreatobiliary and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Johann Pratschke (J)

Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin, Corporate Member of Freie Universität Berlin, and Berlin Institute of Health, Berlin, Germany.

Chung Ngai Tang (CN)

Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.

Charing C Chong (CC)

Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.

Mathieu D'Hondt (M)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.

Chee Chien Yong (CC)

Department of Surgery, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Andrea Ruzzenente (A)

General and Hepatobiliary Surgery, Department of Surgery, Dentistry, Gynecology and Pediatrics, University of Verona, GB Rossi Hospital, Verona, Italy.

Paolo Herman (P)

Liver Surgery Unit, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.

T Peter Kingham (TP)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Olivier Scatton (O)

Department of Digestive, HBP and Liver Transplantation, Hopital Pitie-Salpetriere, Sorbonne Universite, Paris, France.

Rong Liu (R)

Faculty of Hepatopancreatobiliary Surgery, The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Giovanni Battista Levi Sandri (GB)

Division of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Italy.

Olivier Soubrane (O)

Department of Digestive, Oncologic and Metabolic Surgery, Institute Mutualiste Montsouris, Universite Paris Descartes, Paris, France.

Alejandro Mejia (A)

The Liver Institute, Methodist Dallas Medical Center, Texas, Dallas, USA.

Santiago Lopez-Ben (S)

Hepatobiliary and Pancreatic Surgery Unit, Department of Surgery, Dr. Josep Trueta Hospital, IdIBGi, Girona, Spain.

Kazateru Monden (K)

Department of Surgery, Fukuyama City Hospital, Hiroshima, Japan.

Go Wakabayashi (G)

Center for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.

Daniel Cherqui (D)

Department of Hepatobiliary Surgery, Assistance Publique Hopitaux de Paris, Centre Hepato-Biliaire, Paul-Brousse Hospital, Villejuif, France.

Roberto I Troisi (RI)

Department of Clinical Medicine and Surgery, Division of HPB, Minimally Invasive and Robotic Surgery, Federico II University Hospital Naples, Naples, Italy.

Mengqiu Yin (M)

Department of Hepatobiliary Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.

Felice Giuliante (F)

Hepatobiliary Surgery Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Catholic University of the Sacred Heart, Rome, Italy.

David Geller (D)

Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, University of Pittsburgh Medical Center, Pennsylvania, Pittsburgh, USA.

Atsushi Sugioka (A)

Department of Surgery, Fujita Health University School of Medicine, Aichi, Japan.

Bjorn Edwin (B)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Tan-To Cheung (TT)

Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.

Tran Cong Duy Long (TCD)

Department of Hepatopancreatobiliary Surgery, University Medical Center, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.

Mohammad Abu Hilal (MA)

Department of Surgery, University Hospital Southampton, Southampton, UK.
Department of Surgery, Fondazione Poliambulanza, Brescia, Italy.

David Fuks (D)

Department of Digestive, Oncologic and Metabolic Surgery, Institute Mutualiste Montsouris, Universite Paris Descartes, Paris, France.

Kuo-Hsin Chen (KH)

Division of General Surgery, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

Luca Aldrighetti (L)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Ho-Seong Han (HS)

Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.

Brian K P Goh (BKP)

Department of Hepatopancreatobiliary and Transplant Surgery, Division of Surgery, Singapore General Hospital, Singapore, Singapore.
Department of Hepatopancreatobiliary and Transplant Surgery, Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Duke National University of Singapore Medical School, Singapore City, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH